Mykhailo Mudryk Cleared to Play Again After Ban Overturned
Mykhailo Mudryk has been cleared to play again, and with one decision a long, draining saga around his career has been brought to a halt.
The Chelsea winger, 25, has not kicked a ball in competitive football since November 2024, when a four-year suspension dropped on him after a failed drug test revealed a low concentration of meldonium, a banned substance. The sample dated back two years. The ban threatened to cut through the prime of a player Chelsea had once pushed so hard – and paid so heavily – to sign.
Now he is free to return immediately.
A ban overturned by changing science
Mudryk’s case has turned on a crucial shift in how anti-doping authorities interpret traces of meldonium. During his absence, the World Anti-Doping Agency updated its procedures and scientific reporting standards. Under those new thresholds, the level of meldonium detected in his original sample would not even have been reported, let alone pursued as a violation.
The Football Association set out the position bluntly. It confirmed that changes have been made which, while not retroactive, mean that if Mudryk’s sample were taken today, “the concentration of meldonium in the sample would not have been reported and no anti-doping rule violations would have resulted.”
That single detail changed everything.
Mudryk had appealed his sanction to the Court of Arbitration for Sport, fighting a ban that had effectively frozen his career. With WADA’s updated stance now in play, the legal battle has been brought to an agreed close. The FA confirmed that, with WADA’s agreement, the governing body and the player have resolved the appeal proceedings.
There was a condition. As part of the agreement, Mudryk accepted that he had committed the Anti-Doping Rule Violations originally charged and accepted a period of ineligibility equal to the time he has already served. The punishment stands on paper; in practice, it ends here.
The FA’s final line was the one Chelsea and Mudryk have been waiting for: he “is no longer ineligible and may return to competition with immediate effect.”
Chelsea get their £88m winger back
For Chelsea, it closes a chapter that had become as awkward as it was expensive. The club paid £88m to prise Mudryk from Shakhtar Donetsk in January 2023, a statement signing for a side trying to accelerate a new era. Instead, the winger’s story in London stalled under the weight of expectation and then stopped altogether with the ban.
Now they have him back at an age where he should still have time to reshape the narrative of his career.
Chelsea’s own statement underlined what the club see as the key element of the resolution: the science has moved. The club welcomed the acknowledgement that advances in “applicable scientific reporting standards for more reliable testing” mean that, had Mudryk’s sample been analysed under today’s technical requirements, it would not have been reported as a positive test and no anti-doping rule violation would have followed.
For Chelsea, that context matters. It allows them to frame Mudryk’s absence not as a simple case of wrongdoing, but as a product of evolving anti-doping thresholds and interpretation. The club stressed that this is “an important part of the context surrounding the agreed resolution and allows everyone involved to move forward.”
A career restarted
Mudryk returns to a squad that has shifted around him, a league that has not waited, and a club still wrestling with its own rebuild. He comes back cleared, but not untouched: a long stretch of ineligibility, public scrutiny, and a fight through the legal system leaves a mark on any player.
Now the question is simple and unforgiving, the kind football always asks: what does he do with the chance he has just got back?
